Julie E. Bauman, MD, MPH

Deputy Director
Therapeutic Development Program Interim co-leader
Associate Director, Translational Research
Cancer Prevention and Control Program, Research Member
Therapeutic Development Program, Research Member

Biography

Julie E. Bauman, MD, MPH is Professor of Medicine, Chief of Hematology/Oncology, and Associate Director of Translational Research at the University of Arizona Cancer Center. She received her MD/MPH degree from Tufts University, earning election to Alpha Omega Alpha and the MD/MPH Academic Achievement Award in 1999. She completed Internal Medicine Residency at University of Utah in 2003 and Medical Oncology Fellowship at University of Washington in 2006, where she was Chief Fellow. Her education and training, focused at intersection of oncology and public health, resulted in unique expertise in clinical trials for cancer prevention or treatment. Dr. Bauman is a Tucson local; she graduated from Salpointe HS in 1985.

Cancer Focus

Dr. Bauman is an internationally recognized expert in head and neck cancer (HNC). She is funded by the National Cancer Institute (NCI) and the V Foundation to conduct clinical trials to prevent or treat HNC. She leads a broad portfolio of trials evaluating novel immunotherapies in patients with HNC. She is the Co-Principal Investigator of the UACC Cancer Chemoprevention Network, which tests novel cancer prevention agents such as a broccoli-based dietary supplement to reduce tobacco carcinogenesis or HPV vaccination schedules to impart immunity. Dr. Bauman received the NCI Clinical Investigator Team Leadership Award in 2011. She sees patients with HNC and thyroid cancer at the UACC clinic at Banner-University North.